Literature DB >> 10624830

Sex steroids in cervical mucus of spontaneous or induced ovulatory cycles.

D A Adamopoulos1, N Kapolla, A Abrahamian, A Dessypris, S Nicopoulou, G Giannacodemos.   

Abstract

Evaluation of sex steroids in cervical mucus was performed at different phases of spontaneous or clomiphene-citrate-induced ovulatory cycles. To this end, 11 women with normal ovulatory cycles and 9 subjects with polycystic ovary syndrome of comparable age and body mass index were investigated. Serum and cervical mucus samplings were assessed for 17beta-estradiol (E2), progesterone, testosterone, and sex hormone binding globulin levels at the pre-, peri-ovulatory, and mid-luteal phases of the cycle. The cervical mucus maturation index also was estimated in all women. Measurable amounts of E2 were found in most mucus samples with a cyclic variation in all cases. The highest E2 and mucus maturation index values coincided, but both lagged by 24 h behind the serum mid-cycle peak of this steroid. Detectable amounts of progesterone were found in the luteal phase, testosterone was present at low levels throughout the cycle, but sex hormone binding globulin was undetectable in all cervical mucus samples. Differences between spontaneous or drug-induced ovulatory cycles were not found. It is concluded that sex steroids are present in human cervical mucus, showing variations similar to those in peripheral blood. The significance of these findings is not clear at present, but it is probably related to the cyclic changes of cervical epithelium and gland secretion. An important implication of the absence of measurable sex hormone binding globulin amounts in cervical mucus is that the free fraction of sex steroids present in that fluid are presumably higher, and therefore, expected to exert greater biologic activity than in peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10624830     DOI: 10.1016/s0039-128x(99)00074-4

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.

Authors:  Andrea Ries Thurman; Neelima Chandra; Nazita Yousefieh; Irina Zalenskaya; Thomas Kimble; Susana Asin; Christiane Rollenhagen; Sharon M Anderson; Betsy Herold; Pedro M M Mesquita; Nicola Richardson-Harman; Tina Cunningham; Jill L Schwartz; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-10       Impact factor: 2.205

2.  The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception.

Authors:  Jessica Atrio; Alice Stek; Hita Vora; Lorraine Sanchez-Keeland; Ferdous Zannat; Melissa Natavio
Journal:  Eur J Contracept Reprod Health Care       Date:  2014-10-06       Impact factor: 1.848

3.  Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.

Authors:  Lyndsey R Buckner; Erma Z Drobnis; Molly S Augustine; Lynette K Rogers; Jill Akers; Patricia D Mott; Thomas J Hope; Alison J Quayle; Danny J Schust
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.